MIR6888

Across TCGA pan-cancer cohorts, MIR6888 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR6888 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR6888 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6888 expression acts as an unfavorable survival marker.

KIRC, READ, and ESCA are the cancer types where MIR6888 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.517	0.799	.001	87	view →
READ	DFS	Tertile	III,IV	0.174	0.747	.005	42	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
LGG	DFS	Tertile	All	0.139	0.407	<.001	33	view →
SKCM	OS	Tertile	All	0.310	0.784	.001	27	view →
LUAD	OS	Tertile	III,IV	0.228	0.677	.015	18	view →
STAD	OS	Tertile	IV	0.075	0.496	.013	18	view →
SARC	OS	Tertile	All	0.139	0.773	<.001	18	view →
BLCA	DFS	Tertile	All	0.116	0.354	.034	18	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR6888–KIRC (OS)

Open the KIRC breakdown →